MedPage Today on MSN
First-of-Its-Kind Device for Pancreatic Cancer Wins FDA Approval
First approved therapy for locally advanced disease in almost three decades ...
The sam ® long-duration ultrasound device works by generating warmth deep into soft tissue, increasing blood flow and ...
The FDA has approved a first-of-its-kind wearable electrical device — Optune Pax (Novocure) — for patients with locally ...
For millions of Americans with essential tremor, simple tasks like writing a note, putting on makeup or plugging in an appliance can be difficult. | For millions of Americans with essential tremor, ...
Smart ring market leader Oura is trying to convince U.S. lawmakers to loosen some health monitoring regulations for wearable ...
Encora Therapeutics announced today that it has received FDA 510(k) clearance for its Encora X1 wrist-worn device.
Morning Overview on MSN
New FDA-approved device zaps pancreatic cancer with electric fields
The FDA has cleared a wearable device for adults with locally advanced pancreatic cancer that delivers low-intensity electric ...
An FDA-cleared wrist-worn device reliably detects convulsive seizures in epilepsy monitoring units but can miss focal ...
FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and ...
As new consumer hardware and software capabilities have bumped up against medicine over the last few years, consumers and manufacturers alike have struggled with identifying the line between “wellness ...
The Encora X1 utilizes proprietary algorithms to analyze a patient’s tremor in real time. It delivers targeted stimulation to the wrist, modulating the neural pathways responsible for the tremor. The ...
At the forefront of this shift is Nuropod, a U.S.-available, non-invasive, ear-worn vagus nerve stimulation wearable designed to help support reductions in symptoms associated with persistent fatigue, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results